ALCON INC (2U3.DE) Fundamental Analysis & Valuation

FRA:2U3CH0432492467

Current stock price

65.48 EUR
+0.34 (+0.52%)
Last:

This 2U3.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. 2U3.DE Profitability Analysis

1.1 Basic Checks

  • 2U3 had positive earnings in the past year.
  • 2U3 had a positive operating cash flow in the past year.
  • 2U3 had positive earnings in each of the past 5 years.
  • In the past 5 years 2U3 always reported a positive cash flow from operatings.
2U3.DE Yearly Net Income VS EBIT VS OCF VS FCF2U3.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B 1.5B 2B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 3.11%, 2U3 is in line with its industry, outperforming 42.62% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 4.45%, 2U3 is in line with its industry, outperforming 40.98% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 4.32%, 2U3 is doing worse than 62.30% of the companies in the same industry.
  • 2U3 had an Average Return On Invested Capital over the past 3 years of 3.90%. This is significantly below the industry average of 10.18%.
  • The last Return On Invested Capital (4.32%) for 2U3 is above the 3 year average (3.90%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.11%
ROE 4.45%
ROIC 4.32%
ROA(3y)3.25%
ROA(5y)2.45%
ROE(3y)4.63%
ROE(5y)3.51%
ROIC(3y)3.9%
ROIC(5y)3.27%
2U3.DE Yearly ROA, ROE, ROIC2U3.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2 -2 4

1.3 Margins

  • The Profit Margin of 2U3 (9.42%) is better than 68.85% of its industry peers.
  • In the last couple of years the Profit Margin of 2U3 has grown nicely.
  • Looking at the Operating Margin, with a value of 14.32%, 2U3 is in the better half of the industry, outperforming 65.57% of the companies in the same industry.
  • 2U3's Operating Margin has improved in the last couple of years.
  • Looking at the Gross Margin, with a value of 55.78%, 2U3 is in line with its industry, outperforming 45.90% of the companies in the same industry.
  • 2U3's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 14.32%
PM (TTM) 9.42%
GM 55.78%
OM growth 3Y31.29%
OM growth 5YN/A
PM growth 3Y34.84%
PM growth 5YN/A
GM growth 3Y0.68%
GM growth 5Y4.47%
2U3.DE Yearly Profit, Operating, Gross Margins2U3.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40

7

2. 2U3.DE Health Analysis

2.1 Basic Checks

  • 2U3 has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, 2U3 has less shares outstanding
  • Compared to 5 years ago, 2U3 has less shares outstanding
  • The debt/assets ratio for 2U3 has been reduced compared to a year ago.
2U3.DE Yearly Shares Outstanding2U3.DE Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M
2U3.DE Yearly Total Debt VS Total Assets2U3.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

2.2 Solvency

  • An Altman-Z score of 3.97 indicates that 2U3 is not in any danger for bankruptcy at the moment.
  • 2U3's Altman-Z score of 3.97 is fine compared to the rest of the industry. 2U3 outperforms 73.77% of its industry peers.
  • The Debt to FCF ratio of 2U3 is 3.26, which is a good value as it means it would take 2U3, 3.26 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 3.26, 2U3 is in the better half of the industry, outperforming 72.13% of the companies in the same industry.
  • 2U3 has a Debt/Equity ratio of 0.21. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.21, 2U3 is in the better half of the industry, outperforming 68.85% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 3.26
Altman-Z 3.97
ROIC/WACC0.92
WACC4.7%
2U3.DE Yearly LT Debt VS Equity VS FCF2U3.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B 15B 20B

2.3 Liquidity

  • A Current Ratio of 2.12 indicates that 2U3 has no problem at all paying its short term obligations.
  • With a decent Current ratio value of 2.12, 2U3 is doing good in the industry, outperforming 62.30% of the companies in the same industry.
  • 2U3 has a Quick Ratio of 1.33. This is a normal value and indicates that 2U3 is financially healthy and should not expect problems in meeting its short term obligations.
  • 2U3 has a better Quick ratio (1.33) than 63.93% of its industry peers.
Industry RankSector Rank
Current Ratio 2.12
Quick Ratio 1.33
2U3.DE Yearly Current Assets VS Current Liabilites2U3.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

5

3. 2U3.DE Growth Analysis

3.1 Past

  • 2U3 shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 0.33%.
  • Measured over the past years, 2U3 shows a very strong growth in Earnings Per Share. The EPS has been growing by 24.09% on average per year.
  • Looking at the last year, 2U3 shows a small growth in Revenue. The Revenue has grown by 4.94% in the last year.
  • Measured over the past years, 2U3 shows a quite strong growth in Revenue. The Revenue has been growing by 8.77% on average per year.
EPS 1Y (TTM)0.33%
EPS 3Y11.12%
EPS 5Y24.09%
EPS Q2Q%8.33%
Revenue 1Y (TTM)4.94%
Revenue growth 3Y6.06%
Revenue growth 5Y8.77%
Sales Q2Q%9.08%

3.2 Future

  • Based on estimates for the next years, 2U3 will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.43% on average per year.
  • 2U3 is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.35% yearly.
EPS Next Y11.26%
EPS Next 2Y13.39%
EPS Next 3Y13.99%
EPS Next 5Y13.43%
Revenue Next Year7.26%
Revenue Next 2Y6.84%
Revenue Next 3Y7.09%
Revenue Next 5Y6.35%

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
2U3.DE Yearly Revenue VS Estimates2U3.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 5B 10B 15B
2U3.DE Yearly EPS VS Estimates2U3.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3 4 5

4

4. 2U3.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • 2U3 is valuated rather expensively with a Price/Earnings ratio of 24.62.
  • 2U3's Price/Earnings ratio is in line with the industry average.
  • The average S&P500 Price/Earnings ratio is at 25.60. 2U3 is around the same levels.
  • With a Price/Forward Earnings ratio of 22.17, 2U3 is valued on the expensive side.
  • The rest of the industry has a similar Price/Forward Earnings ratio as 2U3.
  • The average S&P500 Price/Forward Earnings ratio is at 22.84. 2U3 is around the same levels.
Industry RankSector Rank
PE 24.62
Fwd PE 22.17
2U3.DE Price Earnings VS Forward Price Earnings2U3.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, 2U3 is valued a bit cheaper than 60.66% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, 2U3 is valued a bit cheaper than 68.85% of the companies in the same industry.
Industry RankSector Rank
P/FCF 23.45
EV/EBITDA 14.61
2U3.DE Per share data2U3.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • The decent profitability rating of 2U3 may justify a higher PE ratio.
  • 2U3's earnings are expected to grow with 13.99% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.19
PEG (5Y)1.02
EPS Next 2Y13.39%
EPS Next 3Y13.99%

2

5. 2U3.DE Dividend Analysis

5.1 Amount

  • With a yearly dividend of 0.47%, 2U3 is not a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 1.17, 2U3 has a dividend in line with its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.90, 2U3's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.47%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
2U3.DE Yearly Dividends per share2U3.DE Yearly Dividends per shareYearly Dividends per share 2026 0.05 0.1 0.15 0.2 0.25

5.3 Sustainability

  • 16.94% of the earnings are spent on dividend by 2U3. This is a low number and sustainable payout ratio.
DP16.94%
EPS Next 2Y13.39%
EPS Next 3Y13.99%
2U3.DE Yearly Income VS Free CF VS Dividend2U3.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B 1.5B
2U3.DE Dividend Payout.2U3.DE Dividend Payout, showing the Payout Ratio.2U3.DE Dividend Payout.PayoutRetained Earnings

2U3.DE Fundamentals: All Metrics, Ratios and Statistics

ALCON INC

FRA:2U3 (4/2/2026, 7:00:00 PM)

65.48

+0.34 (+0.52%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-24
Earnings (Next)N/A
Inst Owners68.03%
Inst Owner ChangeN/A
Ins Owners0.12%
Ins Owner ChangeN/A
Market Cap32.72B
Revenue(TTM)10.40B
Net Income(TTM)980.00M
Analysts78
Price Target92.09 (40.64%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.47%
Yearly Dividend0.29
Dividend Growth(5Y)N/A
DP16.94%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.66%
Min EPS beat(2)-1.57%
Max EPS beat(2)2.89%
EPS beat(4)2
Avg EPS beat(4)0.39%
Min EPS beat(4)-4.26%
Max EPS beat(4)4.49%
EPS beat(8)6
Avg EPS beat(8)2.04%
EPS beat(12)9
Avg EPS beat(12)2.95%
EPS beat(16)11
Avg EPS beat(16)3.98%
Revenue beat(2)0
Avg Revenue beat(2)-1.53%
Min Revenue beat(2)-1.53%
Max Revenue beat(2)-1.52%
Revenue beat(4)0
Avg Revenue beat(4)-2.36%
Min Revenue beat(4)-3.43%
Max Revenue beat(4)-1.52%
Revenue beat(8)0
Avg Revenue beat(8)-1.92%
Revenue beat(12)2
Avg Revenue beat(12)-1.1%
Revenue beat(16)3
Avg Revenue beat(16)-0.57%
PT rev (1m)0.87%
PT rev (3m)-0.8%
EPS NQ rev (1m)-1.74%
EPS NQ rev (3m)-2.1%
EPS NY rev (1m)-1%
EPS NY rev (3m)-3.31%
Revenue NQ rev (1m)0.15%
Revenue NQ rev (3m)0.15%
Revenue NY rev (1m)-0.12%
Revenue NY rev (3m)-0.06%
Valuation
Industry RankSector Rank
PE 24.62
Fwd PE 22.17
P/S 3.63
P/FCF 23.45
P/OCF 16.61
P/B 1.71
P/tB 10
EV/EBITDA 14.61
EPS(TTM)2.66
EY4.06%
EPS(NY)2.95
Fwd EY4.51%
FCF(TTM)2.79
FCFY4.26%
OCF(TTM)3.94
OCFY6.02%
SpS18.06
BVpS38.26
TBVpS6.55
PEG (NY)2.19
PEG (5Y)1.02
Graham Number47.85
Profitability
Industry RankSector Rank
ROA 3.11%
ROE 4.45%
ROCE 5.22%
ROIC 4.32%
ROICexc 4.58%
ROICexgc 14.26%
OM 14.32%
PM (TTM) 9.42%
GM 55.78%
FCFM 15.46%
ROA(3y)3.25%
ROA(5y)2.45%
ROE(3y)4.63%
ROE(5y)3.51%
ROIC(3y)3.9%
ROIC(5y)3.27%
ROICexc(3y)4.13%
ROICexc(5y)3.45%
ROICexgc(3y)12.95%
ROICexgc(5y)11.34%
ROCE(3y)4.71%
ROCE(5y)3.95%
ROICexgc growth 3Y30.67%
ROICexgc growth 5YN/A
ROICexc growth 3Y37.24%
ROICexc growth 5YN/A
OM growth 3Y31.29%
OM growth 5YN/A
PM growth 3Y34.84%
PM growth 5YN/A
GM growth 3Y0.68%
GM growth 5Y4.47%
F-Score7
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 3.26
Debt/EBITDA 1.63
Cap/Depr 49.66%
Cap/Sales 6.37%
Interest Coverage 7.84
Cash Conversion 80.42%
Profit Quality 164.08%
Current Ratio 2.12
Quick Ratio 1.33
Altman-Z 3.97
F-Score7
WACC4.7%
ROIC/WACC0.92
Cap/Depr(3y)58.03%
Cap/Depr(5y)76.08%
Cap/Sales(3y)7.39%
Cap/Sales(5y)10.1%
Profit Quality(3y)119.07%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0.33%
EPS 3Y11.12%
EPS 5Y24.09%
EPS Q2Q%8.33%
EPS Next Y11.26%
EPS Next 2Y13.39%
EPS Next 3Y13.99%
EPS Next 5Y13.43%
Revenue 1Y (TTM)4.94%
Revenue growth 3Y6.06%
Revenue growth 5Y8.77%
Sales Q2Q%9.08%
Revenue Next Year7.26%
Revenue Next 2Y6.84%
Revenue Next 3Y7.09%
Revenue Next 5Y6.35%
EBIT growth 1Y4.64%
EBIT growth 3Y39.25%
EBIT growth 5YN/A
EBIT Next Year50.46%
EBIT Next 3Y21.86%
EBIT Next 5Y16.5%
FCF growth 1Y14.29%
FCF growth 3YN/A
FCF growth 5Y44.41%
OCF growth 1Y9.34%
OCF growth 3Y23.11%
OCF growth 5Y22.51%

ALCON INC / 2U3.DE Fundamental Analysis FAQ

What is the ChartMill fundamental rating of ALCON INC (2U3.DE) stock?

ChartMill assigns a fundamental rating of 6 / 10 to 2U3.DE.


What is the valuation status for 2U3 stock?

ChartMill assigns a valuation rating of 4 / 10 to ALCON INC (2U3.DE). This can be considered as Fairly Valued.


What is the profitability of 2U3 stock?

ALCON INC (2U3.DE) has a profitability rating of 6 / 10.


Can you provide the financial health for 2U3 stock?

The financial health rating of ALCON INC (2U3.DE) is 7 / 10.


What is the expected EPS growth for ALCON INC (2U3.DE) stock?

The Earnings per Share (EPS) of ALCON INC (2U3.DE) is expected to grow by 11.26% in the next year.